Erminia Massarelli

Also affiliated with The University of Texas Health Science Center at Tyler

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The association of sociodemographic variables with smoking prevalence in patients enrolled on clinical trials.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13595

Top 100%

0DataRank

Top 100%0 citations

Riha Vaidya, Cathee Till, Kimlin Ashing, Graham Warren, Dawn L. Hershman +13 more

Papers

Driven by 24 papers — median percentile 0. Top paper: “Phase II Trial of Lung Chemoembolization”.

Phase II Trial of Lung Chemoembolization

Journal of Vascular and Interventional Radiology(2023)10.1016/j.jvir.2023.08.006

N/A

0.201DataRank · unranked

2 citations

Ravi Salgia, Thomas C. Waddington, Erminia Massarelli, John J. Park, Jonathan Kessler +4 more

An LC–MS/MS Method for Simultaneous Determination of LB-100 and Its Active Metabolite, Endothall, in Human Plasma

Bioanalysis(2023)10.4155/bio-2023-0078

N/A

0.104DataRank · unranked

1 citations

Erminia Massarelli, Eric Forman, John S. Kovach, Ravi Salgia, Timothy W. Synold +1 more

A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung Cancer

iScience(2020)10.1016/j.isci.2020.101496

N/A

0DataRank · unranked

42 citations

Arin Nam, Alexander Pozhitkov, Lu Yang, Saumya Srivastava, Anusha Nathan +14 more

Co-stimulatory and co-inhibitory Immune Markers in Solid Tumors With MET Alterations

Future Science OA(2020)10.2144/fsoa-2020-0159

N/A

0DataRank · unranked

2 citations

Jasmine A. McQuerry, Isa Mambetsariev, Rebecca Pharaon, Susan E. Yost, Jeremy Fricke +14 more

Evaluation of immune-related adverse events in patients treated with sequential immunotherapy and tyrosine kinase inhibitor treatment in non-small cell lung cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e21562

N/A

0DataRank · unranked

0 citations

Isa Mambetsariev, Jeremy Fricke, Rebecca Pharaon, Dan Zhao, Marianna Koczywas +3 more

Alterations in STK11 to limit response to immune checkpoint inhibitors in lung cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e21503

N/A

0DataRank · unranked

0 citations

Isa Mambetsariev, Rebecca Pharaon, Angel Ray Baroz, Dan Zhao, Erminia Massarelli +3 more

Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients With Non-small Cell Lung Cancer

CHEST Journal(2021)10.1016/j.chest.2021.04.016

N/A

0DataRank · unranked

44 citations

Isa Mambetsariev, Rebecca Pharaon, Jeremy Fricke, Hatim Husain, Karen L. Reckamp +5 more

Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade Chemotherapy

Biomolecules(2021)10.3390/biom12010008

N/A

0DataRank · unranked

24 citations

Atish Mohanty, S. Bhattacharya, Sourabh Kotnala, Srisairam Achuthan, Kishore Hari +14 more

The Association between Polluted Neighborhoods andTP53-Mutated Non–Small Cell Lung Cancer

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-20-1555

N/A

0DataRank · unranked

21 citations

Sam E. Wing, Jenny Shen, Hengrui Hu, Ernesto Sosa, Lisa Lopez +19 more

Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer

Journal of Clinical Medicine(2022)10.3390/jcm11051429

N/A

0DataRank · unranked

32 citations

Leonidas Arvanitis, Jeremy Fricke, Rebecca Pharaon, Angel Ray Baroz, Michelle Afkhami +4 more

Integration of artificial intelligence in lung cancer: Rise of the machine

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.100933

N/A

0DataRank · unranked

70 citations

Arya Amini, Ameish Govindarajan, Isa Mambetsariev, Dan J. Raz, Erminia Massarelli +4 more

Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer

Science Advances(2023)10.1126/sciadv.ade3816

N/A

0DataRank · unranked

68 citations

Arin Nam, Saumya Srivastava, Jeff Jones, Brett Lomenick, Sharad S. Singhal +30 more

Predicting survival of NSCLC patients treated with immune checkpoint inhibitors: Impact and timing of immune-related adverse events and prior tyrosine kinase inhibitor therapy

Frontiers in Oncology(2023)10.3389/fonc.2023.1064169

N/A

0DataRank · unranked

14 citations

Isa Mambetsariev, Kun‐Han Lu, Chi Wah Wong, Ashley Duche, Richard Beuttler +10 more

A phase 1 trial of umbilical cord blood–derived tumor-reactive PD-L1+ natural killer cells engineered to express soluble IL-15 (TRACK-NK) in patients with non–small-cell lung cancer (NSCLC) refractory to PD-1/PD-L1 inhibitors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps2665

N/A

0DataRank · unranked

4 citations

Stephen J. Forman, Joycelynne Palmer, Timothy W. Synold, Lei Tian, Ting Lu +14 more

Data from High Expression of ErbB Family Members and Their Ligands in Lung Adenocarcinomas That Are Sensitive to Inhibition of Epidermal Growth Factor Receptor

(2023)10.1158/0008-5472.c.6494705.v1

N/A

0DataRank · unranked

0 citations

Marie Wislez, Jie Zhang, Kentaro Iwanaga, Jennifer Dackor, Amy E. Hanna +14 more

Data from High Expression of ErbB Family Members and Their Ligands in Lung Adenocarcinomas That Are Sensitive to Inhibition of Epidermal Growth Factor Receptor

(2023)10.1158/0008-5472.c.6494705

N/A

0DataRank · unranked

0 citations

Marie Wislez, Jie Zhang, Kentaro Iwanaga, Jennifer Dackor, Amy E. Hanna +14 more

The association of sociodemographic variables with smoking prevalence in patients enrolled on clinical trials.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13595

Top 100%

0DataRank

Top 100%0 citations

Riha Vaidya, Cathee Till, Kimlin Ashing, Graham Warren, Dawn L. Hershman +13 more

RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung Cancer

Clinical Lung Cancer(2024)10.1016/j.cllc.2024.07.010

N/A

0DataRank · unranked

6 citations

Michelle Afkhami, Erminia Massarelli, Jeremy Fricke, Isa Mambetsariev, Xiaochen Li +3 more

Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome

npj Precision Oncology(2024)10.1038/s41698-024-00626-6

N/A

0DataRank · unranked

4 citations

Haiqing Li, Isa Mambetsariev, Tamara Mirzapoiazova, Chen Chen, Jeremy Fricke +13 more

Smoking prevalence and association with sociodemographic variables in cancer clinical trial participants

Cancer(2024)10.1002/cncr.35560

N/A

0DataRank · unranked

2 citations

Cathee Till, Riha Vaidya, Kimlin Ashing, Graham Warren, Virginia Sun +11 more

Dynamic phenotypic switching and group behavior help non-small cell lung cancer cells evade chemotherapy

(2024)10.22541/au.170668208.89175591/v1

N/A

0DataRank · unranked

0 citations

Atish Mohanty, S. Bhattacharya, Sourabh Kotnala, Srisairam Achuthan, Kishore Hari +14 more

Precision medicine and actionable alterations in lung cancer: A single institution experience

PLoS ONE(2020)10.1371/journal.pone.0228188

N/A

0DataRank · unranked

9 citations

Yingyu Wang, Chen Chen, Sorena Nadaf, Rebecca Pharaon, Jeremy Fricke +19 more

Research Priorities for Malignant Pleural Organization with Loculation and Failed Drainage

Cells(2025)10.3390/cells14141118

N/A

0DataRank · unranked

0 citations

Erminia Massarelli, Luis Destarac, Steven Idell, Torry A. Tucker

Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival

Journal of Thoracic Disease(2020)10.21037/jtd.2020.04.18

N/A

0DataRank · unranked

46 citations

Isa Mambetsariev, Rohan Gupta, Srisairam Achuthan, Yingyu Wang, Rebecca Pharaon +5 more

Erminia Massarelli

Indexed papers

Top data-sharing exemplar

Papers